Facebook Megamin Activ Twitter Megamin Activ

 

Proven to fight cancerogenic.
diseases.

TMA-Z has been proven to fight the following cancerogenic diseases:

  • skin cancer
  • cervical cancer
  • breast cancer
  • ovarian cancer
  • cancer of liver & spleen
  • cancer of small intestine
  • cancer of large intestine
  • lung cancer
  • bone cancer
  • stomach cancer
  • cancer of the bladder
  • tonque cancer
  • thyroid gland cancer
 

See how Megamin Activ can help you.

It has been undisputedly confirmed that Megamin Activ is a very effective oxidoreductive preparation, and probably the most powerful antioxidant in the world that is taken orally.

Please select your condition

How it can help you

Circulatory System stabilisation and optimisation of functioning of the circulatory system along with improved blood pressure and reduced varicosity of the veins, reduction of and complete recovery from oedema, swollen veins, haemorrhoids, and disappearance of enlarged capillaries. strengthening of the heart muscle, acceleration of post heart attack recuperation.

There was marked improvement in blood count for all those tested along with value correction in respect of raised levels of cholesterol and threeglycerides, as well as other substances (haemoglobin).

stabilization and optimal regulation of the digestive system, along with elimination of and recuperation from damage or disturbances such as heart-burn, stomach and duodenal ulcers.

Treatment of all types of rheumatic disorders, including sciatica, discopathy, spondilosis, arthritis, rheumatic arthritis.

Diuretic effect and positive influence in improving kidney function. treatment of kidney infection.

Treatment of skin diseases such as: seborrhea, dermatitis, herpes (all types), psoriasis, and others, through peroral intake and external application of powder.

In most of those tested there was clear stabilization and decrease in the level of sugar in the blood.

Optimization of endocrine gland activity, especially in the lymph nodes.

Accelerated healing of wounds with direct application of powder. direct application of powder to minor burns temporarily relieves pain and eliminates skin damage.

Treatment of periodontosis and elimination of micro-organisms in the mouth with powder applied directly to the gums or as an additive to toothpaste.

Increased moisture, as well as significantly increasing resistance to various negative external factors including UV rays.

Successful treatment of insomnia, neurosis, depression. aids in the treatment of epilepsy, schizophrenia, Alzheimer’s disease, Parkinson’s disease.

Increased endurance in situations of increased physical effort, reduction or elimination of pain resulting from increased physical exertion.

Quick and complete elimination of various fungal infections of the skin (Candida and others) and mucous membrane with direct application of powder. elimination of fungal foot infections. Treatment of fungal infections on internal organs, which can result from radiological procedures in combination with antibiotics.

Scientifically proven results

The first researches on the Megamin Activ project, began in the spring of 1997, first at the Faculty of Food Technology and Biotechnology, University in Zagreb.

The public very quickly became interested in the positive effects noted in volunteers who had just begun to use Megamin Activ as well as in those who had been using Megamin Activ for a longer period of time

Influence on diabetes mellitus

Investigations were carried out on mice, who 7 days after being induced with diabetes mellitus were fed for 14 days with 50, 100 or 200 mg of Megamin Activ per mouse. The result was restoration of body weight to an even slightly greater degree than in the control group, as well as improved glucose tolerance, which normalised after only 2 hours following injection of 1 g of glucose per kilogram of body weight. Not one of the doses studied produced a hypoglycaemic reaction.

Results in vivo

Mice were inoculated with melanoma B16 cells, and were then given Megamin Activ twice a day orally for 5 days. Observation of tumour volume confirmed that Megamin Activ reduced tumour volume in mice.

Results in vivo

Studies on tumour patients in the USA

Testing was carried out on 5 patients (2 female, 3 male) between the ages of 35 and 77, all in critical condition. One female patient was diagnosed with hypernephroma lat.sin. The patient refused surgery and chemotherapy, and was in very poor physical and psychological condition. She began taking Megamin Activ and after a short period of time her overall condition significantly improved, she gained weight and began to walk (which she had previously been unable to do). Another female patient was diagnosed with cervical cancer with metastasis in the bones.

Studies on tumour patients in the USA

Testing was carried out on 5 patients (2 female, 3 male) between the ages of 35 and 77, all in critical condition. One female patient was diagnosed with hypernephroma lat.sin. The patient refused surgery and chemotherapy, and was in very poor physical and psychological condition. She began taking Megamin Activ and after a short period of time her overall condition significantly improved, she gained weight and began to walk (which she had previously been unable to do). Another female patient was diagnosed with cervical cancer with metastasis in the bones. After two rounds of chemotherapy she began taking Megamin Activ in capsule and powder form, which resulted in a 50% reduction in the tumour and significant improvement in overall condition. The male patients were suffering from lymphosarcoma femoris l.sin, multiplemetastases, pancreatic cancer and intestinal cancer with metastasis. All began taking Megamin Activ in capsule and powder form in large doses (24-40 capsules) which quickly resulte in significant improvement in overall condition.

Studies on tumour patients in Croatia

Conclusion

With a series of results documenting the positive effects of tribomechanically activated zeolite in a series of anecdotal cases involving various health problems in people, scientific research was begun in 1997 to investigate the potential effects on biological systems. The scientific investigations included testing the acute, subacute and chronic toxicity of Megamin Activ, effects of Megamin Activ on various canine tumours, Megamin Activ influence on cancer (in vivo and in vitro), on diabetes mellitus, in liver disease, the possibilities for use of Megamin Activ in the treatment of wounds, in neurodegenerative diseases, in transitory hypogamaglobulonaemia, as well as testing its antioxidative effects. Results of investigations so far, as well as use in practice, indicate the necessity to continue to the research, with a multicentre approach and with various goals. It has definitely been confirmed that Megamin Activ is a very effective oxidoreductive preparation, and probably the most powerful antioxidant in the world that is taken orally. Therefore, in this phase of the research the conclusion can already be drawn that its use as a roborant in adjuvant therapies, as well as for prophylaxis and improvement of immunity in healthy people is to be recommended.

Megamin Activ products

Proven Quality.

In the process of making Megamin Activ, the clinoptilolite is activated into grains smaller than 226 nm, and its bioactivity and bioavailability are also increased up to 1000 %.

Shop now
 

Save

Save

Save

Save